KIA
CORT icon

KCM Investment Advisors’s Corcept Therapeutics CORT Stock Holding History

KCM Investment Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Sell
41,238
-6,157
-13% -$372K 0.11% 114
2026
Q1 		$1.91M Hold
47,395
– – 0.06% 162
2025
Q4 		$1.65M Sell
47,395
-260
-0.5% -$20.4K 0.05% 177
2025
Q3 		$3.96M Hold
47,655
– – 0.13% 107
2025
Q2 		$3.5M Hold
47,655
– – 0.12% 114
2025
Q1 		$5.44M Sell
47,655
-7,000
-13% -$426K 0.2% 86
2024
Q4 		$2.75M Sell
54,655
-2,771
-5% -$145K 0.1% 133
2024
Q3 		$2.66M Hold
57,426
– – 0.09% 140
2024
Q2 		$1.87M Buy
57,426
+200
+0.3% +$5.48K 0.07% 156
2024
Q1 		$1.44M Buy
57,226
+4,026
+8% +$95.1K 0.05% 186
2023
Q4 		$1.73M Sell
53,200
-200
-0.4% -$5.49K 0.07% 163
2023
Q3 		$1.45M Sell
53,400
-64,157
-55% -$1.86M 0.06% 175
2023
Q2 		$2.62M Buy
117,557
+42,636
+57% +$981K 0.1% 137
2023
Q1 		$1.62M Buy
74,921
+7,382
+11% +$162K 0.07% 174
2022
Q4 		$1.37M Hold
67,539
– – 0.06% 187
2022
Q3 		$1.73M Hold
67,539
– – 0.08% 160
2022
Q2 		$1.61M Buy
67,539
+3,182
+5% +$69.3K 0.07% 176
2022
Q1 		$1.45M Sell
64,357
-4,000
-6% -$85.1K 0.05% 190
2021
Q4 		$1.35M Sell
68,357
-6,360
-9% -$129K 0.05% 198
2021
Q3 		$1.47M Buy
74,717
+34,628
+86% +$725K 0.06% 181
2021
Q2 		$882K Hold
40,089
– – 0.04% 216
2021
Q1 		$954K Buy
40,089
+200
+0.5% +$5.34K 0.04% 205
2020
Q4 		$1.04M Hold
39,889
– – 0.05% 184
2020
Q3 		$694K Hold
39,889
– – 0.04% 193
2020
Q2 		$671K Buy
+39,889
New +$560K 0.04% 201

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM Investment Advisors's CORT Position: Q2 2026 in Review

KCM Investment Advisors reduced its Corcept Therapeutics (CORT) stake by 13% in Q2 2026, selling an estimated $372K and leaving 41,238 shares worth $3.59M. The position accounts for 0.11% of the portfolio, ranked #114.

KCM Investment Advisors first reported a position in CORT in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.44M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • KCM Investment Advisors held 41,238 shares of Corcept Therapeutics worth $3.59M as of Q2 2026.
  • KCM Investment Advisors sold 6,157 Corcept Therapeutics shares in Q2 2026, an estimated $372K.
  • Corcept Therapeutics made up 0.11% of KCM Investment Advisors's portfolio in Q2 2026, its #114 holding.
  • KCM Investment Advisors first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • KCM Investment Advisors's Corcept Therapeutics position peaked at $5.44M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.